Metreleptin worked in a diabetic woman with a history of hematopoietic stem cell transplantation (HSCT) during infancy: further support for the concept of 'HSCT-associated lipodystrophy'.
In conclusion, metreleptin is useful for the management of HSCT-associated lipodystrophy, supporting the concept that adipose tissue dysfunction is responsible for diverse post-HSCT metabolic aberrations.
PMID: 33229817 [PubMed - as supplied by publisher]
Source: Endocrine Journal - Category: Endocrinology Tags: Endocr J Source Type: research
More News: Cholesterol | Diabetes | Endocrinology | Fatty Liver Disease (FLD) | Insulin | Leukemia | Liver | Liver Transplant | Stem Cell Therapy | Stem Cells | Study | Transplants | Urology & Nephrology